{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T05:15:06Z","timestamp":1722834906441},"reference-count":41,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.3892\/ol.2015.3652","type":"journal-article","created":{"date-parts":[[2015,8,27]],"date-time":"2015-08-27T07:10:31Z","timestamp":1440659431000},"page":"3274-3278","source":"Crossref","is-referenced-by-count":3,"title":["DNA copy number gains in malignant pleural mesothelioma"],"prefix":"10.3892","volume":"10","author":[{"given":"MASASHI","family":"FURUKAWA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHINICHI","family":"TOYOOKA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TATSURO","family":"HAYASHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIROMASA","family":"YAMAMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NOBUKAZU","family":"FUJIMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JUNICHI","family":"SOH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHINSUKE","family":"HASHIDA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KAZUHIKO","family":"SHIEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIROAKI","family":"ASANO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KEISUKE","family":"AOE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KAZUNORI","family":"OKABE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HARVEY I.","family":"PASS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KAZUNORI","family":"TSUKUDA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKUMI","family":"KISHIMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHINICHIRO","family":"MIYOSHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,8,27]]},"reference":[{"key":"key20180108100726_b1-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/oem.51.12.804","article-title":"Malignant mesothelioma: Attributable risk of asbestos exposure","volume":"51","author":"Spirtas","year":"1994","journal-title":"Occup Environ Med"},{"key":"key20180108100726_b2-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/bjc.1998.42","article-title":"Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung","volume":"77","author":"Bj\u00f6rkqvist","year":"1998","journal-title":"Br J Cancer"},{"key":"key20180108100726_b3-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1349-7006.2006.00386.x","article-title":"Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32","volume":"98","author":"Taniguchi","year":"2007","journal-title":"Cancer Sci"},{"key":"key20180108100726_b4-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/modpathol.2008.45","article-title":"Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas","volume":"21","author":"Chiosea","year":"2008","journal-title":"Mod Pathol"},{"key":"key20180108100726_b5-ol-0-0-3652","first-page":"1","article-title":"Advances in the molecular biology of malignant mesothelioma","volume":"62","author":"Toyooka","year":"2008","journal-title":"Acta Med Okayama"},{"key":"key20180108100726_b6-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1038\/sj.onc.1206593","article-title":"Hemizygosity of Nf2 is associated with increased susceptibility to asbestos-induced peritoneal tumours","volume":"22","author":"Fleury-Feith","year":"2003","journal-title":"Oncogene"},{"key":"key20180108100726_b7-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.cancergen.2012.08.005","article-title":"Heterozygous loss of NF2 is an early molecular alteration in well-differentiated papillary mesothelioma of the peritoneum","volume":"205","author":"Nemoto","year":"2012","journal-title":"Cancer Genet"},{"key":"key20180108100726_b8-ol-0-0-3652","first-page":"2610","article-title":"p53 and Kirsten-ras mutations in human mesothelioma cell lines","volume":"52","author":"Metcalf","year":"1992","journal-title":"Cancer Res"},{"key":"key20180108100726_b9-ol-0-0-3652","first-page":"425","article-title":"Mutational analysis of N-ras, p53, p16INK4a, p14ARF and CDK4 genes in primary human malignant mesotheliomas","volume":"18","author":"Papp","year":"2001","journal-title":"Int J Oncol"},{"key":"key20180108100726_b10-ol-0-0-3652","first-page":"5727","article-title":"Aberrant methylation and simian virus 40 tag sequences in malignant mesothelioma","volume":"61","author":"Toyooka","year":"2001","journal-title":"Cancer Res"},{"key":"key20180108100726_b11-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.lungcan.2008.02.013","article-title":"Frequent p16 inactivation by homozygous deletion or methylation is associated with a poor prognosis in Japanese patients with pleural mesothelioma","volume":"62","author":"Kobayashi","year":"2008","journal-title":"Lung Cancer"},{"key":"key20180108100726_b12-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1158\/0008-5472.CAN-09-1595","article-title":"Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma","volume":"69","author":"Goto","year":"2009","journal-title":"Cancer Res"},{"key":"key20180108100726_b13-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2559.2008.03178.x","article-title":"Problems in mesothelioma diagnosis","volume":"54","author":"Addis","year":"2009","journal-title":"Histopathology"},{"key":"key20180108100726_b14-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1002\/ijc.25285","article-title":"Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma","volume":"127","author":"Gee","year":"2010","journal-title":"Int J Cancer"},{"key":"key20180108100726_b15-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5858\/arpa.2010-0604-RA","article-title":"Immunohistochemistry and molecular diagnostics of pleural malignant mesothelioma","volume":"136","author":"Betta","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"key20180108100726_b16-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","article-title":"International Mesothelioma Interest Group: Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group","volume":"137","author":"Husain","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"key20180108100726_b17-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"6913","DOI":"10.1158\/0008-5472.CAN-07-5084","article-title":"PIK3CA mutations and copy number gains in human lung cancers","volume":"68","author":"Yamamoto","year":"2008","journal-title":"Cancer Res"},{"key":"key20180108100726_b18-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"e7464","DOI":"10.1371\/journal.pone.0007464","article-title":"Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells","volume":"4","author":"Soh","year":"2009","journal-title":"PLoS One"},{"key":"key20180108100726_b19-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/ijc.24150","article-title":"MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors","volume":"124","author":"Kubo","year":"2009","journal-title":"Int J Cancer"},{"key":"key20180108100726_b20-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/JTO.0b013e31820594f0","article-title":"Evaluation of Kras gene mutation and copy number gain in non-small cell lung cancer","volume":"6","author":"Sasaki","year":"2011","journal-title":"J Thorac Oncol"},{"key":"key20180108100726_b21-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.1158\/0008-5472.CAN-04-4603","article-title":"Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single-nucleotide polymorphism array analysis","volume":"65","author":"Zhao","year":"2005","journal-title":"Cancer Res"},{"key":"key20180108100726_b22-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"e9112","DOI":"10.1371\/journal.pone.0009112","article-title":"Sex-determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung","volume":"5","author":"Yuan","year":"2010","journal-title":"PLoS One"},{"key":"key20180108100726_b23-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00428-012-1250-y","article-title":"FGFR1 expression and gene copy numbers in human lung cancer","volume":"461","author":"Kohler","year":"2012","journal-title":"Virchows Arch"},{"key":"key20180108100726_b24-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1097\/JTO.0b013e31826aed28","article-title":"FGFR1 amplification in squamous cell carcinoma of the lung","volume":"7","author":"Heist","year":"2012","journal-title":"J Thorac Oncol"},{"key":"key20180108100726_b25-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3892\/etm.2011.374","article-title":"Increased SOX2 copy number in lung squamous cell carcinomas","volume":"3","author":"Sasaki","year":"2012","journal-title":"Exp Ther Med"},{"key":"key20180108100726_b26-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1158\/0008-5472.CAN-04-4567","article-title":"Functional analysis of c-met hepatocyte growth factor pathway in malignant pleural mesothelioma","volume":"66","author":"Jagadeeswaran","year":"2006","journal-title":"Cancer Res"},{"key":"key20180108100726_b27-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1141478","article-title":"MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling","volume":"316","author":"Engelman","year":"2007","journal-title":"Science"},{"key":"key20180108100726_b28-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1158\/1078-0432.CCR-05-0934","article-title":"Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay","volume":"12","author":"Asano","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20180108100726_b29-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00432-008-0384-4","article-title":"Epidermal growth factor receptor gene mutation, amplification and protein expression in malignant pleural mesothelioma","volume":"134","author":"Okuda","year":"2008","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20180108100726_b30-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/jso.21901","article-title":"Epidermal growth factor receptor overexpression in malignant pleural mesothelioma: Prognostic correlations","volume":"104","author":"Rena","year":"2011","journal-title":"J Surg Oncol"},{"key":"key20180108100726_b31-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1440-1827.2011.02778.x","article-title":"A comparison of epidermal growth factor receptor expression in malignant peritoneal and pleural mesothelioma","volume":"62","author":"Enomoto","year":"2012","journal-title":"Pathol Int"},{"key":"key20180108100726_b32-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/jclinpath-2011-200208","article-title":"Genomic gains and losses in malignant mesothelioma demonstrated by FISH analysis of paraffin-embedded tissues","volume":"65","author":"Takeda","year":"2012","journal-title":"J Clin Pathol"},{"key":"key20180108100726_b33-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.lungcan.2005.10.016","article-title":"EGFR overexpression in malignant pleural mesothelioma. An immunohistochemical and molecular study with clinico-pathological correlations","volume":"51","author":"Destro","year":"2006","journal-title":"Lung Cancer"},{"key":"key20180108100726_b34-ol-0-0-3652","first-page":"333","article-title":"Increased epidermal growth factor-receptor protein in a human mesothelial cell line in response to long asbestos fibers","volume":"152","author":"Pache","year":"1998","journal-title":"Am J Pathol"},{"key":"key20180108100726_b35-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ijc.21271","article-title":"Common EGFR mutations conferring sensitivity to gefitinib in lung adenocarcinoma are not prevalent in human malignant mesothelioma","volume":"118","author":"Cortese","year":"2006","journal-title":"Int J Cancer"},{"key":"key20180108100726_b36-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/JTO.0b013e31819c8661","article-title":"Absence of mutations in the epidermal growth factor receptor (EGFR) kinase domain in patients with mesothelioma","volume":"4","author":"Velcheti","year":"2009","journal-title":"J Thorac Oncol"},{"key":"key20180108100726_b37-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/bjc.2013.130","article-title":"Mutation analysis of the EGFR gene and downstream signalling pathway in histologic samples of malignant pleural mesothelioma","volume":"108","author":"Mezzapelle","year":"2013","journal-title":"Br J Cancer"},{"key":"key20180108100726_b38-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1056\/NEJMoa050736","article-title":"Erlotinib in lung cancer - molecular and clinical predictors of outcome","volume":"353","author":"Tsao","year":"2005","journal-title":"N Engl J Med"},{"key":"key20180108100726_b39-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1470-2045(05)70102-9","article-title":"Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study","volume":"6","author":"Moroni","year":"2005","journal-title":"Lancet Oncol"},{"key":"key20180108100726_b40-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1158\/1078-0432.CCR-04-1940","article-title":"Cancer and Leukemia Group B (CALGB 30101): Gefitinib in patients with malignant mesothelioma: A phase II study by the Cancer and Leukemia Group B","volume":"11","author":"Govindan","year":"2005","journal-title":"Clin Cancer Res"},{"key":"key20180108100726_b41-ol-0-0-3652","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1200\/JCO.2006.09.7634","article-title":"Phase II study of erlotinib in patients with malignant pleural mesothelioma: A Southwest Oncology Group Study","volume":"25","author":"Garland","year":"2007","journal-title":"J Clin Oncol"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2015.3652\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T07:39:26Z","timestamp":1515397166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2015.3652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,27]]},"references-count":41,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,8,27]]},"published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.3892\/ol.2015.3652"],"URL":"https:\/\/doi.org\/10.3892\/ol.2015.3652","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,27]]}}}